ICD-10-CM Billable Code

Q78.0

Osteogenesis imperfecta

Clinical Classification Guidelines

Inclusion Terms

  • Fragilitas ossium
  • Osteopsathyrosis

Medical Intelligence & Overview

Osteogenesis imperfecta, commonly known as brittle bone disease, is a genetic disorder characterized by fragile bones that break easily. This condition varies in severity, from mild cases with few fractures to more severe forms involving multiple fractures throughout life. It is present at birth and can affect individuals of all ages. The disorder results from defective collagen production, which impairs bone strength and structure. Besides bones, osteogenesis imperfecta can also affect other tissues containing collagen, leading to additional health concerns such as joint issues, dental problems, and hearing loss.

Causes & Symptoms

Clinical Causes: Genetic mutations affecting collagen production, primarily the COL1A1 and COL1A2 genes. Inherited in an autosomal dominant pattern, meaning a mutation from one parent can cause the disorder. Rare cases occur due to new mutations with no family history. Environmental factors do not directly cause the disorder, but early diagnosis can help manage symptoms effectively.

Key Symptoms: Repeated fractures occurring with minimal or no trauma. Bone deformities such as bowed limbs or a curved spine. Short stature due to affected bone growth. Loose joints and ligament laxity. Blue, gray, or translucent sclerae (the whites of the eyes). Dentinogenesis imperfecta, leading to fragile or discolored teeth. Auditory issues, including hearing loss, often beginning in adolescence or early adulthood. Reduced muscle strength and mobility challenges. Frequent bone pain or tenderness.

Diagnostic & Treatment

Diagnosis Path: Diagnosis of osteogenesis imperfecta involves a combination of clinical evaluation, family history assessment, and diagnostic tests. Key approaches include: - Physical examination to observe bone deformities and other characteristic features. - Medical imaging, such as X-rays, to identify fractures, bone deformities, and areas of weakened bone. - Genetic testing to detect mutations in the COL1A1 and COL1A2 genes. - Bone density scans (DEXA) may support diagnosis but are less definitive. Early detection often occurs in infancy or childhood when fractures or symptoms first manifest, guiding management decisions.

Treatment Protocols: While there is no cure for osteogenesis imperfecta, various treatment strategies can improve quality of life and reduce fracture risk: - Medications such as bisphosphonates to increase bone density. - Physical therapy to enhance muscle strength, mobility, and prevent contractures. - Use of braces, splints, or orthopedic devices to support bones and improve function. - Surgical procedures, including rodding surgeries, to stabilize and strengthen affected bones. - Managing dental issues with appropriate dental care. - Hearing assessments and interventions for auditory problems. - Ensuring a safe environment to minimize falls and injury. Multidisciplinary care involving orthopedists, geneticists, dentists, and physical therapists is essential for comprehensive management.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is Q78.0 a billable ICD-10 code?
Yes, Q78.0 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report Q78.0?
Clinical documentation must specify the nature of Osteogenesis imperfecta and any associated comorbidities for accurate reporting.

Cite this Clinical Reference

Related Diagnosis Codes

Clinical Meta Tags

imperfecta osteogenesis